Journal
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
Publication Date
5-1-2022
Volume
23
Issue
3-4
First Page
263
Last Page
270
Document Type
Open Access Publication
DOI
10.1080/21678421.2021.1946083
Rights and Permissions
Rudnicki SA, Andrews JA, Genge A, Jackson C, Lechtzin N, Miller TM, Cockroft BM, Malik FI, Meng L, Wei J, Wolff AA, Shefner JM; FORTITUDE-ALS STUDY GROUP. Prescription and acceptance of durable medical equipment in FORTITUDE-ALS, a study of reldesemtiv in ALS: post hoc analyses of a randomized, double-blind, placebo-controlled clinical trial. Amyotroph Lateral Scler Frontotemporal Degener. 2022 May;23(3-4):263-270. doi.org/10.1080/21678421.2021.1946083 © 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.
Recommended Citation
Rudnicki, Stacy A; Andrews, Jinsy A; Genge, Angela; Jackson, Carlayne; Lechtzin, Noah; Miller, Timothy M; Cockroft, Bettina M; Malik, Fady I; Meng, Lisa; Wei, Jenny; Wolff, Andrew A; Shefner, Jeremy M; and FORTITUDE-ALS STUDY GROUP, "Prescription and acceptance of durable medical equipment in FORTITUDE-ALS, a study of reldesemtiv in ALS: Post hoc analyses of a randomized, double-blind, placebo-controlled clinical trial." Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 23, 3-4. 263 - 270. (2022).
https://digitalcommons.wustl.edu/open_access_pubs/11972
Supplementary Table 1